Related Experiment Video
Updated: Jul 19, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Features of Myocarditis: Morphological Differential Diagnosis in Post-COVID-19 Children
Vadim Karev1,2, Anastasia Ya Starshinova3, Anzhela Glushkova4
1Children's Clinical Research Center for Infectious Diseases, St. Petersburg 194100, Russia.
Insights
Diagnosing myocarditis, especially from SARS-CoV-2 infection, requires reconsidering morphological criteria beyond PCR. Histopathological changes offer key markers for this cardiovascular inflammation in children and adults.
Area of Science:
- Cardiology
- Pathology
- Infectious Diseases
Background:
- Myocarditis involves cardiomyocyte dysfunction, inflammation, and fibrosis, posing a global health challenge.
- Late diagnosis of myocarditis is a significant issue, exacerbated by novel coronavirus infections like COVID-19.
- Understanding viral etiologies, including SARS-CoV-2, is crucial for accurate myocarditis diagnosis.
Purpose of the Study:
- To differentiate myocarditis of viral etiology, specifically SARS-CoV-2, using instrumental and pathomorphological findings.
- To review and analyze diagnostic criteria for myocarditis associated with viral infections.
Main Methods:
- Systematic review of publications from December 2019 to May 2023.
- Searched major international databases (Medline, PubMed, Scopus).
- Keywords included: myocarditis, children, cardiovascular inflammation, COVID-19, SARS-CoV-2, and differential diagnosis.
Main Results:
- No definitive morphological criteria for SARS-CoV-2-associated myocarditis were identified.
- Key histopathological markers for SARS-CoV-2 infection include virus-associated degeneration, apoptosis, cardiomyocyte necrosis, hyperemia, edema, and capillary endothelial dysfunction.
- These findings highlight specific changes in myocardial tissue during SARS-CoV-2 infection.
Conclusions:
- Relying solely on PCR for viral RNA is insufficient for diagnosing SARS-CoV-2 myocarditis; morphological criteria need re-evaluation.
- Similar diagnostic challenges exist for myocarditis linked to other viral infections.
- An etiological diagnosis requires a comprehensive approach: virus exposure confirmation, clinical symptoms, imaging (MRI/CT), and morphological data.
Abstract:
Myocarditis is characterized by dysfunction and destruction of cardiomyocytes, infiltrative inflammation, and development of fibrosis. Late diagnosis of myocarditis has been a serious global health problem, especially due to the spread of a new coronavirus infection. The aim of this review is to identify differences between myocarditis of viral etiology, including SARS-CoV-2 lesions, based on instrumental and pathomorphological findings.
Material And Methods:
We analyzed publications covering the period from December 2019 to May 2023, published in publicly accessible international databases ("Medline", "PubMed", "Scopus"), with queries for the keywords "myocarditis", "children", "cardiovascular inflammation", "COVID-19", "SARS-CoV-2", "severe acute respiratory syndrome coronavirus 2", "differential diagnosis".
Results:
It was found that no unambiguous morphological criteria for the diagnosis of myocarditis coupled to SARS-CoV-2 lesions were identified. However, the detected histopathological changes such as virus-associated degeneration, apoptosis, cardiomyocyte necrosis, moderate interstitial hyperemia, myocardial tissue oedema, and capillary endothelial cell dysfunction were the major markers of SARS-CoV-2 infection.
Conclusion:
It is necessary further reconsider morphological criteria to diagnose SARS-CoV-2-caused myocarditis, rather than solely relying on detecting viral RNA by PCR as the sole evidence-based criterion. Similar issues accompany diagnostics of myocardial lesions associated with other viral infections. Evidence for an etiological diagnosis of myocarditis can be provided by a comprehensive analysis of the diagnostic criteria obtained, confirming virus exposure, followed by development of distinct clinical symptoms, MRI and CT changes, and morphological criteria.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cardiomyopathy I: Introduction and Classification

